NIH to Grant Exclusive License for Retroviral Infection Treatment

Summary

The National Institutes of Health (NIH) is considering granting an exclusive license to practice certain inventions related to treating retroviral infections with a phorbol ester derivative, owned by the AIDS Research Alliance of America, to the US government.